In our annual edition of the VC Valuations Report, our analysts delve into sizes and valuations of US VC deals in 2019, highlighting deals with nontraditional investor participation and a breakout of US VC valuations by select sectors, including pharma & biotech, fintech and artificial intelligence & machine learning. Our analysts also examine how the characteristics that diversify nontraditional investors make them particularly equipped to participate in VC deals, allowing them to post significantly larger deal sizes and valuations than traditional VCs in 2019. In addition, this report provides insight into the downward trend of median valuation step-ups at the time of an IPO.
Interested in sponsoring future editions of this report? Visit our media partnerships page to learn more.